Back to Search
Start Over
Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders
- Source :
- Digital.CSIC. Repositorio Institucional del CSIC, instname
- Publication Year :
- 2014
-
Abstract
- et al.<br />The aim of the present study was to develop a novel strategy to deliver intracellularly the peptide GSE24.2 for the treatment of Dyskeratosis congenita (DC) and other defective telomerase disorders. For this purpose, biodegradable polymeric nanoparticles using poly(lactic-co-glycolic acid) (PLGA NPs) or poly(lactic-co-glycolic acid)-poly ethylene glycol (PLGA-PEG NPs) attached to either polycations or cell-penetrating peptides (CPPs) were prepared in order to increase their cellular uptake. The particles exhibited an adequate size and zeta potential, with good peptide loading and a biphasic pattern obtained in the in vitro release assay, showing an initial burst release and a later sustained release. GSE24.2 structural integrity after encapsulation was assessed using SDS-PAGE, revealing an unaltered peptide after the NPs elaboration. According to the cytotoxicity results, cell viability was not affected by uncoated polymeric NPs, but the incorporation of surface modifiers slightly decreased the viability of cells. The intracellular uptake exhibited a remarkable improvement of the internalization, when the NPs were conjugated to the CPPs. Finally, the bioactivity, addressed by measuring DNA damage rescue and telomerase reactivation, showed that some formulations had the lowest cytotoxicity and highest biological activity. These results proved that GSE24.2-loaded NPs could be delivered to cells, and therefore, become an effective approach for the treatment of DC and other defective telomerase syndromes.<br />Susana P. Egusquiaguirre thanks the Basque Government (Gobierno Vasco, Departamento de Educación, Universidades e Investigación) for the fellowship research grant. C. Manguan-García is supported by CIBER de Enfermedades Raras. This project was partially supported by the Basque Government (Consolidated Groups, IT-407-07), MINECO from the Spanish Government (INNPACTO, IPT-2012-0674-090000). The authors gratefully acknowledge the support of University of the Basque Country UPV/EHU (UFI11/32). Besides, this work was also supported by grant PI11-00949 (supported by FEDER funds) from Instituto Carlos III.
- Subjects :
- Telomerase
Chemical Phenomena
Cell Survival
Drug Compounding
Pharmaceutical Science
Peptide
Biocompatible Materials
Cell Cycle Proteins
Cell-Penetrating Peptides
Dyskeratosis Congenita
Cell Line
Polyethylene Glycols
chemistry.chemical_compound
Mice
Drug Delivery Systems
Enzyme Reactivators
Drug Stability
Polylactic Acid-Polyglycolic Acid Copolymer
Zeta potential
Polyamines
Animals
Humans
Viability assay
Lactic Acid
Cytotoxicity
Polyglactin 910
Cells, Cultured
chemistry.chemical_classification
Protein Stability
technology, industry, and agriculture
Nuclear Proteins
Biological Transport
General Medicine
Polyelectrolytes
In vitro
Peptide Fragments
Recombinant Proteins
PLGA
Drug Liberation
chemistry
Biochemistry
Delayed-Action Preparations
Biophysics
Nanoparticles
Ethylene glycol
Polyglycolic Acid
Biotechnology
Subjects
Details
- ISSN :
- 18733441
- Volume :
- 91
- Database :
- OpenAIRE
- Journal :
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
- Accession number :
- edsair.doi.dedup.....e4dc205c711d474c962afe592335450d